[Cardiovascular system research at the Institute of Drug Research].
The most significant achievements in the cardiovascular research areas have been reviewed. Among the beta-adrenoceptor blockers, antihypertensive, positive inotropic, and antiarrhythmic compounds synthesized and investigated at the IDR, a number of new drug candidates have been found and studied in clinical phases. One compound has been marketed (Tobanum, beta-adrenoceptor blocker).
Mátyus
P
P
Semmelweis Egyetem, Szerves Vegytani Intézet, Budapest, Hógyes E. u. 7, H-1092.
D000047:Academies and Institutes; D000319:Adrenergic beta-Antagonists / Q000138:chemical synthesis; D000889:Anti-Arrhythmia Agents / Q000138:chemical synthesis; D000959:Antihypertensive Agents / Q000138:chemical synthesis; D002316:Cardiotonic Agents / Q000138:chemical synthesis; D002317:Cardiovascular Agents / Q000138:chemical synthesis* / Q000737:chemistry; D004345:Drug Industry / Q000639:trends; D006814:Hungary; D015394:Molecular Structure; D012106:Research / Q000639:trends
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D000959:Antihypertensive Agents; D002316:Cardiotonic Agents; D002317:Cardiovascular Agents
Kardiovaszkuláris hatóanyagok kutatása a Gyógyszerkutató Intézetben.